ZURA | Zura Bio Limited Class ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$3.99
+$0.05 (+1.27%)

Zura Bio Limited Class A (ZURA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $3.99 vs 50 $4.58 / 200 $5.23
Projection
No cross projected
Test
No active test
Last cross
Death cross 2 Oct 2026 ยท projected 19 bars out

Weekly

No weekly data

4-hour as of 3 Nov 16:00 ET

Price
below both $3.99 vs 50 $4.03 / 200 $4.91
Projection
No cross projected
Test
No active test
Last cross
Death cross 2 Oct 2026 ยท projected 28 bars out

Cross history

9
crosses on record since 2024
4 golden5 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Oct 2026Death moderatedaily19 bars outNot tested
2 Oct 2026Death4-hour28 bars outNot tested
21 Aug 2026Golden steepdaily20 bars out1 bar cross test
18 Jun 2026Death steepdaily28 bars out2 bar cross test
9 Sep 2025Golden steepdaily17 bars outNot tested

About ZURA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$8.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2024
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.